Galactose therapy reduces proteinuria in patients with recurrent focal segmental glomerulosclerosis after kidney transplantation

Publisher： John Wiley & Sons Inc

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.S1, 2015-03, pp. : 13-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1109-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 96-100

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focal segmental glomerular sclerosis recurrence with massive proteinuria and anuria immediately after kidney transplantation

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 93-95

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Interactions Between TRPC6 and NPHS1 Variants Affect Posttransplant Risk of Recurrent Focal Segmental Glomerulosclerosis

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 12, 2015-12 ,pp. : 3229-3238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focal Segmental Glomerulosclerosis – Does Treatment Work?

By  

Nephron Clin Pract, Vol. 104, Iss. 2, 2006-06 ,pp. : c83-c84

Karger

Access to resources Recommend Favorite